A detailed history of Raymond James & Associates transactions in Boston Scientific Corp stock. As of the latest transaction made, Raymond James & Associates holds 1,327,349 shares of BSX stock, worth $120 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,327,349
Previous 1,152,055 15.22%
Holding current value
$120 Million
Previous $88.7 Million 25.37%
% of portfolio
0.07%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$72.96 - $84.0 $12.8 Million - $14.7 Million
175,294 Added 15.22%
1,327,349 $111 Million
Q2 2024

Jul 19, 2024

SELL
$67.33 - $77.71 $851,589 - $982,876
-12,648 Reduced 1.09%
1,152,055 $88.7 Million
Q1 2024

Apr 22, 2024

SELL
$57.6 - $68.62 $971,769 - $1.16 Million
-16,871 Reduced 1.43%
1,164,703 $79.8 Million
Q4 2023

Jan 16, 2024

BUY
$48.64 - $57.81 $2.14 Million - $2.54 Million
44,000 Added 3.87%
1,181,574 $68.3 Million
Q3 2023

Oct 24, 2023

SELL
$50.19 - $54.68 $1.37 Million - $1.5 Million
-27,389 Reduced 2.35%
1,137,574 $60.1 Million
Q2 2023

Jul 25, 2023

SELL
$49.72 - $54.64 $7.49 Million - $8.23 Million
-150,578 Reduced 11.45%
1,164,963 $63 Million
Q1 2023

Apr 14, 2023

SELL
$45.09 - $50.03 $1.7 Million - $1.89 Million
-37,792 Reduced 2.79%
1,315,541 $65.8 Million
Q4 2022

Feb 08, 2023

BUY
$39.56 - $47.22 $4.65 Million - $5.55 Million
117,602 Added 9.52%
1,353,333 $62.6 Million
Q3 2022

Oct 25, 2022

SELL
$36.71 - $109.66 $21.1 Million - $63.1 Million
-575,643 Reduced 31.78%
1,235,731 $47.9 Million
Q2 2022

Aug 12, 2022

SELL
$35.24 - $47.1 $2.11 Million - $2.82 Million
-59,914 Reduced 3.2%
1,811,374 $67.5 Million
Q1 2022

May 11, 2022

SELL
$40.9 - $45.1 $12.7 Million - $14 Million
-310,350 Reduced 14.23%
1,871,288 $82.9 Million
Q4 2021

Feb 08, 2022

SELL
$38.07 - $44.87 $8.55 Million - $10.1 Million
-224,583 Reduced 9.33%
2,181,638 $92.7 Million
Q3 2021

Nov 02, 2021

BUY
$41.23 - $45.88 $2.55 Million - $2.84 Million
61,808 Added 2.64%
2,406,221 $104 Million
Q2 2021

Aug 11, 2021

BUY
$38.58 - $44.24 $12.9 Million - $14.8 Million
334,503 Added 16.64%
2,344,413 $100 Million
Q1 2021

May 14, 2021

BUY
$35.27 - $39.67 $14.9 Million - $16.8 Million
423,096 Added 26.66%
2,009,910 $77.7 Million
Q4 2020

Feb 12, 2021

BUY
$33.15 - $41.97 $11.7 Million - $14.8 Million
352,727 Added 28.58%
1,586,814 $57 Million
Q3 2020

Nov 04, 2020

BUY
$34.44 - $42.23 $2.93 Million - $3.59 Million
85,025 Added 7.4%
1,234,087 $47.2 Million
Q2 2020

Jul 28, 2020

BUY
$30.19 - $39.11 $2.74 Million - $3.55 Million
90,842 Added 8.58%
1,149,062 $40.3 Million
Q1 2020

Apr 21, 2020

BUY
$25.83 - $45.71 $2.31 Million - $4.08 Million
89,354 Added 9.22%
1,058,220 $34.5 Million
Q4 2019

Feb 12, 2020

BUY
$37.87 - $45.37 $4.89 Million - $5.86 Million
129,201 Added 15.39%
968,866 $43.8 Million
Q3 2019

Nov 07, 2019

BUY
$40.31 - $43.45 $4.19 Million - $4.52 Million
103,915 Added 14.12%
839,665 $34.2 Million
Q2 2019

Aug 06, 2019

BUY
$34.91 - $42.98 $1.43 Million - $1.76 Million
40,874 Added 5.88%
735,750 $31.6 Million
Q1 2019

May 06, 2019

BUY
$32.91 - $40.75 $2.49 Million - $3.08 Million
75,571 Added 12.2%
694,876 $26.7 Million
Q4 2018

Feb 11, 2019

BUY
$31.73 - $39.04 $3.24 Million - $3.99 Million
102,169 Added 19.76%
619,305 $21.9 Million
Q3 2018

Nov 14, 2018

BUY
$32.83 - $38.63 $1.44 Million - $1.69 Million
43,734 Added 9.24%
517,136 $19.9 Million
Q2 2018

Aug 14, 2018

SELL
$26.84 - $34.32 $477,805 - $610,964
-17,802 Reduced 3.62%
473,402 $15.5 Million
Q1 2018

May 14, 2018

SELL
$25.2 - $28.54 $3.27 Million - $3.7 Million
-129,791 Reduced 20.9%
491,204 $13.4 Million
Q4 2017

Feb 14, 2018

SELL
$24.79 - $29.8 $578,920 - $695,919
-23,353 Reduced 3.62%
620,995 $15.4 Million
Q3 2017

Nov 13, 2017

BUY
$26.26 - $29.17 $773,094 - $858,764
29,440 Added 4.79%
644,348 $18.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
614,908
614,908 $17 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.